{"id":"https://openalex.org/W2013248985","doi":"https://doi.org/10.1016/j.ejcsup.2013.07.040","title":"Successful clinical translation of preclinical combinations of radiation and immunotherapy","display_name":"Successful clinical translation of preclinical combinations of radiation and immunotherapy","publication_year":2013,"publication_date":"2013-09-01","ids":{"openalex":"https://openalex.org/W2013248985","doi":"https://doi.org/10.1016/j.ejcsup.2013.07.040","mag":"2013248985"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejcsup.2013.07.040","doi":"https://doi.org/10.1016/j.ejcsup.2013.07.040","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejcsup.2013.07.040","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359634913000414/pdf","source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S1359634913000414/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017673781","display_name":"Silvia Chiara Formenti","orcid":"https://orcid.org/0000-0002-8227-8924","observed_orcids":["https://orcid.org/0000-0002-8227-8924"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Silvia C. Formenti","raw_affiliation_strings":["New York University School of Medicine, New York University Cancer Institute, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, New York University Cancer Institute, USA","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052554629","display_name":"Sandra Demaria","orcid":"https://orcid.org/0000-0003-4426-0499","observed_orcids":["https://orcid.org/0000-0003-4426-0499"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Demaria","raw_affiliation_strings":["New York University School of Medicine, New York University Cancer Institute, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, New York University Cancer Institute, USA","institution_ids":["https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017673781"],"corresponding_institution_ids":["https://openalex.org/I57206974"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10466651,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"2","first_page":"270","last_page":"270"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.5979999899864197},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5329999923706055},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.847000002861023},{"id":"https://openalex.org/keywords/abscopal-effect","display_name":"abscopal effect","score":0.9610000252723694},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.8560000061988831},{"id":"https://openalex.org/keywords/immunological-synapse","display_name":"immunological synapse","score":0.7689999938011169},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.8240000009536743},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8330000042915344},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.7960000038146973},{"id":"https://openalex.org/keywords/clinical-translation","display_name":"clinical translation","score":0.40400001406669617}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.642920196056366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6099746227264404},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5801799297332764},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5594545602798462},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5251010656356812},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.512990415096283},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4991722106933594},{"id":"https://openalex.org/C2781274730","wikidata":"https://www.wikidata.org/wiki/Q4669679","display_name":"Abscopal effect","level":4,"score":0.47611531615257263},{"id":"https://openalex.org/C151872237","wikidata":"https://www.wikidata.org/wiki/Q1410759","display_name":"Homing (biology)","level":2,"score":0.4635689854621887},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4563174843788147},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.4184984564781189},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41425517201423645},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4112401604652405},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3726041913032532},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22440749406814575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1155661940574646},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07553359866142273},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ejcsup.2013.07.040","doi":"https://doi.org/10.1016/j.ejcsup.2013.07.040","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejcsup.2013.07.040","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359634913000414/pdf","source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3224062","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4041317","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4041317","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4041317","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJC Suppl","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.ejcsup.2013.07.040","doi":"https://doi.org/10.1016/j.ejcsup.2013.07.040","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejcsup.2013.07.040","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359634913000414/pdf","source":{"id":"https://openalex.org/S13410216","display_name":"European Journal of Cancer Supplements","issn_l":"1359-6349","issn":["1359-6349","1878-1217"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","norway-1","poland-100","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer Supplements","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2013248985.pdf","grobid_xml":"https://content.openalex.org/works/W2013248985.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2046834643","https://openalex.org/W2075879891","https://openalex.org/W2133739473","https://openalex.org/W2140828776"],"related_works":["https://openalex.org/W2163632499","https://openalex.org/W183727606","https://openalex.org/W4409821428","https://openalex.org/W2560952875","https://openalex.org/W1068438862","https://openalex.org/W2090883361","https://openalex.org/W2132429759","https://openalex.org/W1605743112","https://openalex.org/W2487203639","https://openalex.org/W2286391085"],"abstract_inverted_index":{"Ionising":[0],"radiation":[1,149,461],"(IR)":[2],"can":[3,29,39,345],"induce":[4],"immunogenic":[5],"cell":[6],"death":[7],"in":[8,49,53,69,114,132,137,220,310,320,337,367,379,385,420],"tumours,":[9,123,210,280],"an":[10,48,126,229,362],"effect":[11,128],"likely":[12],"to":[13,15,36,42,99,157,161,167,184,342,358,424,444,453],"contribute":[14,41],"the":[16,44,87,133,138,162,171,185,201,215,226,258,271,297,332,347,352,446],"success":[17,68,295],"associated":[18],"with":[19,75,94,118,152,212,222,284],"radiotherapy":[20,28],"(RT)":[21],"for":[22],"cancer.":[23,145],"Recent":[24],"studies":[25,131],"suggest":[26,330],"that":[27,148,177,190,331,416],"be":[30],"applied":[31],"as":[32,125,198],"a":[33,81,91,100,155,175,425],"powerful":[34],"adjuvant":[35],"immunotherapy,":[37],"and":[38,74,97,107,109,194,236,249,287,302,313,390,398,432,440,451],"even":[40],"converting":[43],"irradiated":[45,279,319],"tumour":[46,72,223,259,285,291,404],"into":[47],"situ":[50],"vaccine,":[51],"resulting":[52],"specific":[54],"immunity":[55],"against":[56],"metastases":[57,120],"[1].\r\n\r\nImportantly,":[58],"preclinical":[59,88,294,380],"models":[60,141,339,381],"of":[61,90,102,116,121,142,174,180,203,217,228,273,296,299,334,354,373,388,396,427,449,459],"syngeneic":[62,139],"tumours":[63],"have":[64,85,417],"reliably":[65],"predicted":[66],"clinical":[67,327,368,386],"several":[70,76],"distinct":[71],"settings":[73],"different":[77],"immunotherapy/radiation":[78],"combinations.":[79],"As":[80],"proof-of-principle":[82],"trial,":[83],"we":[84],"translated":[86],"evidence":[89,437],"successful":[92],"combination":[93,298],"Flt3":[95],"ligand":[96],"RT":[98,397,410],"protocol":[101],"granulocyte\u2013monocyte":[103],"colony-stimulating":[104],"factor":[105,406],"(GM-CSF)":[106],"IR,":[108],"demonstrated":[110,189,384,413],"out-of-field":[111],"objective":[112],"responses":[113,308,375],"27%":[115],"patients":[117,318,355],"multiple":[119],"solid":[122],"defined":[124],"abscopal":[127,307,374,414],"[2]\r\n\r\nIn-parallel":[129],"mechanistic":[130],"laboratory":[134],"were":[135],"conducted":[136],"mouse":[140],"metastatic":[143,311],"breast":[144,391],"Results":[146],"showed":[147],"was":[150,262,304,382],"synergistic":[151],"anti-CTLA-4":[153,213,274,300],"treatment,":[154,361],"strategy":[156],"break":[158],"immune":[159,230,349],"tolerance":[160],"tumor.":[163,186],"Multiple":[164],"mechanisms":[165],"contributed":[166],"thus":[168],"synergy,":[169],"including":[170],"RT-induced":[172],"upregulation":[173],"chemokine":[176],"promoted":[178],"homing":[179],"effector":[181],"T":[182,206,218,234,247,276],"cells":[183,207,219,235,248,277,286],"Intravital":[187],"microscopy":[188],"while":[191],"both":[192],"IR":[193,211,303,335,344],"CTLA-4":[195],"blockade":[196,360],"given":[197],"monotherapy":[199],"enhanced":[200],"motility":[202,272],"activated":[204],"CD8":[205],"infiltrating":[208],"4T1":[209],"increased":[214,270],"arrest":[216],"contact":[221,283],"cells,":[224,260],"promoting":[225],"formation":[227],"synapse":[231],"between":[232,243],"cytotoxic":[233],"their":[237,282],"targets.":[238],"The":[239,370],"latter":[240],"required":[241],"interaction":[242],"NKG2D":[244],"on":[245,257],"CD8+":[246],"its":[250],"ligand,":[251],"retinoic":[252],"acid":[253],"early":[254],"inducible-1":[255],"(Rae-1),":[256],"which":[261],"up-regulated":[263],"by":[264,306,394],"IR.":[265],"Blocking":[266],"NKG2D\u2013Rae-1":[267],"interactions":[268],"markedly":[269],"treated":[275,393],"within":[278],"inhibiting":[281],"also":[288,383],"abrogated":[289],"immune-mediated":[290],"rejection":[292],"[4].\r\n\r\nThe":[293],"antibody":[301,430],"mirrored":[305],"seen":[309],"melanoma":[312],"non-small-cell":[314],"lung":[315],"cancer":[316],"(NSCLC)":[317],"one":[321,421],"lesion":[322],"during":[323,409],"ipilimumab":[324],"therapy.":[325],"These":[326],"observations":[328],"strongly":[329],"effects":[333,415],"identified":[336],"experimental":[338],"are":[340],"relevant":[341],"patients.":[343],"stimulate":[346],"anti-tumor":[348],"response,":[350],"increasing":[351],"proportion":[353],"who":[356],"respond":[357],"checkpoint":[359],"hypothesis":[363],"currently":[364],"being":[365],"tested":[366],"trials.":[369],"same":[371],"pattern":[372],"has":[376,412],"been":[377,418],"observed":[378],"cases":[387],"lymphomas":[389],"cancers":[392],"combinations":[395,448],"toll-like":[399],"receptor":[400],"agonists.":[401],"Finally,":[402],"blocking":[403],"growth":[405],"beta":[407],"(TGF-beta)":[408],"preclinically":[411],"confirmed":[419],"patient":[422],"accrued":[423],"trial":[426],"anti-human":[428],"TGFb":[429],"fresolimumab":[431],"RT.":[433],"While":[434],"promising,":[435],"this":[436,456],"remains":[438],"preliminary":[439],"warrants":[441],"more":[442],"research":[443],"define":[445],"optimal":[447],"immunotherapy":[450],"RT,":[452],"best":[454],"exploit":[455],"novel":[457],"role":[458],"ionising":[460],"[3].":[462]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}